Pcn22 - Marketing Authorisation Practice of the European Medicines Agency (Ema) in Oncological Indications

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pro Labeling in Products Approved by the European Medicines Agency (EMA) for Narcolepsy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

What Is the European Medicines Agency?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2012English

Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Is European Medicines Agency (EMA) Sepsis Criteria Accurate for Neonatal Sepsis Diagnosis or Do We Need New Criteria?

PLoS ONE
Multidisciplinary
2019English

FDA Reform and the European Medicines Evaluation Agency

Harvard Law Review
Law
1995English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies

mAbs
AllergyImmunology
2009English

Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency

Frontiers in Plant Science
Plant Science
2020English

European Medicines Agency Policies for Clinical Trials Leave Women Unprotected

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy